Literature DB >> 2601563

Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry.

M E Morgan1, R E Vestal.   

Abstract

The effects of caffeine (1,3,7-trimethylxanthine) and theophylline (1,3-dimethylxanthine) on caudate dopamine release were examined in urethane anesthetized and freely moving rats using in vivo electrochemistry. In anesthetized animals, all doses (150, 250, and 500 mumole/kg, i.p.) produced significant decreases in caudate dopamine (DA) release, which were 14%, 30% and 58%, respectively, at 30 min. The decrease in caudate DA release appeared to be a selective effect with respect to drug and brain region. D-amphetamine (37 mumole/kg, i.p.) increased the caudate signal over a 150 min period. Caffeine, 250 mumole/kg, increased norepinephrine (NE) release in hippocampus by 37% at 30 min and 58% at 150 min. Motor cortical NE release was increased by 8% at 30 min and 44% at 150 min. In freely moving rats, caffeine and theophylline, 75 mumole/kg, increased caudate DA release by 39% and 66%, respectively, at 60 min. Caffeine, 250 and 500 mumole/kg, decreased caudate DA release by 31% and 52%, respectively, at 30 min. Theophylline, 250 mumole/kg, increased release by 25% at 75 min. A 500 mumole/kg dose of theophylline decreased caudate DA release by 44% at 30 min. Measurement of caudate methylxanthine concentrations showed that caudate caffeine levels were significantly higher than those of theophylline. These data are the first to show in an intact animal that methylxanthines affect the regional release of catecholamines (CA) in the central nervous system. This effect is dose dependent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2601563     DOI: 10.1016/0024-3205(89)90577-8

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

2.  Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesia.

Authors:  Hsien-yang Lee; Junko Nakayama; Ying Xu; Xueliang Fan; Maha Karouani; Yiguo Shen; Emmanuel N Pothos; Ellen J Hess; Ying-Hui Fu; Robert H Edwards; Louis J Ptácek
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

3.  No effect of caffeine on exercise performance in high ambient temperature.

Authors:  Bart Roelands; Luk Buyse; Frank Pauwels; Frans Delbeke; Koen Deventer; Romain Meeusen
Journal:  Eur J Appl Physiol       Date:  2011-04-02       Impact factor: 3.078

4.  Effect of caffeine on the intraocular pressure in patients with primary open angle glaucoma.

Authors:  Peeyush Chandra; Ajit Gaur; Shambhu Varma
Journal:  Clin Ophthalmol       Date:  2011-11-16

5.  The role of adenosine A1 and A2A receptors in the caffeine effect on MDMA-induced DA and 5-HT release in the mouse striatum.

Authors:  A M Górska; K Gołembiowska
Journal:  Neurotox Res       Date:  2014-11-13       Impact factor: 3.911

6.  Effect of coffee (caffeine) against human cataract blindness.

Authors:  Shambhu D Varma
Journal:  Clin Ophthalmol       Date:  2016-01-27

7.  Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier.

Authors:  Kei Ikeda-Murakami; Naoto Tani; Tomoya Ikeda; Yayoi Aoki; Takaki Ishikawa
Journal:  Int J Mol Sci       Date:  2022-02-07       Impact factor: 5.923

8.  Protective effect of caffeine against high sugar-induced transcription of microRNAs and consequent gene silencing: a study using lenses of galactosemic mice.

Authors:  Shambhu D Varma; Svitlana Kovtun
Journal:  Mol Vis       Date:  2013-02-25       Impact factor: 2.367

9.  Caffeine induces sustained apoptosis of human gastric cancer cells by activating the caspase‑9/caspase‑3 signalling pathway.

Authors:  Hanyang Liu; Yan Zhou; Liming Tang
Journal:  Mol Med Rep       Date:  2017-06-30       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.